
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings is a leader in the medical device industry with a significant presence in the growing EP market. Despite a recent downward adjustment in customer forecasts for select EP products, the core EP market remains robust and the company is well-positioned to navigate ongoing regulatory risks and competition from larger competitors. Additionally, the company announced a strategic review, which reflects the current attractive valuations in the medtech landscape and offers potential for increased shareholder value through a sale, merger, or business combination.
Bears say
Integer Holdings is facing challenges with decreasing revenue and non-GAAP adjusted EPS for the second quarter, mainly due to a decline in Cardio & Vascular and Other Markets sales, along with operational investments. Additionally, concerns over the impact of new trade tariffs, increased long-term debt, and lowered financial guidance for 2026 has led to a negative outlook. The impending sale transaction further adds uncertainty to the company's future prospects. As a result, the outlook for Integer Holdings is negative, with estimated decreases in revenue and earnings for the third quarter of 2026 and for the full year 2026.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares